Neurostimulation of the Cholinergic Antiinflammatory Pathway in Rheumatoid Arthritis and Inflammatory Bowel Disease

Bioelectronic Medicine

Volumn 1, Issue 1, 2014, Pages 34-43

  Levine, Yaakov A ^a   Koopman, Frieda ^b   Faltys, Michael ^a   Zitnik, Ralph ^a   Tak, Paul Peter ^c,d,e  

^a Setpoint Medical Corporation   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bioelectronic Medicine; Cholinergic Anti inflammatory Pathway; Dysregulated Inflammation; Implantable Medical Devices; Significant Therapeutic Advances

Indexed keywords

BIOMEDICAL EQUIPMENT; PATHOLOGY; PATIENT TREATMENT;

ANTI-INFLAMMATORIES; BIOELECTRONIC MEDICINE; CHOLINERGIC ANTI-INFLAMMATORY PATHWAY; DYSREGULATED INFLAMMATION; IMPLANTABLE MEDICAL DEVICES; INFLAMMATORY BOWEL DISEASE; MEDICAL NEEDS; NEUROSTIMULATION; RHEUMATOID ARTHRITIS; SIGNIFICANT THERAPEUTIC ADVANCE;

DISEASES;

EID: 84977742291     PISSN: None     EISSN: 23328886     Source Type: Journal    
DOI: 10.15424/bioelectronmed.2014.00008     Document Type: Article

References (56)

1. Scott DL, Wolfe F, Huizinga TW. (2010) Rheumatoid arthritis. Lancet. 376:1094–108.
2. Cheifetz AS. (2013) Management of active Crohn disease. JAMA. 309:2150–8.
3. Gkaliagkousi E, et al. (2012) Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J. Clin. Rheumatol. 18:422–30.
4. Andersson U, Tracey KJ. (2012) Reflex principles of immunological homeostasis. Annu. Rev. Immunol. 30:313–35.
5. Tracey KJ. (2009) Reflex control of immunity. Nat. Rev. Immunol. 9:418–428.
6. Watkins LR, et al. (1995) Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immunebrain communication. Neurosci. Lett. 183:27–31.
7. Bianchi M, et al. (1995) An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1:254–266.
8. Borovikova L, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405:458–62.
9. Huston JM, et al. (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203:1623–8.
10. Rosas-Ballin M, et al. (2008) Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. U. S. A. 105:11008–13.
11. Rosas-Ballina M, et al. (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 334:98–101.
12. Wang H, et al. (2003) Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation. Nature. 421:384–8.
13. Olofsson PS, et al. (2012) alpha7 nicotinic acetylcholine receptor (alpha7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol. Med. 18:539–43.
14. Matteoli G, Boeckxstaens GE. (2013) The vagal innervation of the gut and immune homeostasis. Gut. 62:1214–22.
15. Matteoli G, et al. (2014) A distinct vagal antiinflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut. 63:938–4.
16. Ji H, et al. (2014) Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunol. 7:335–47.
17. Bruchfeld A, et al. (2010) Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J. Intern. Med. 268:94–101.
18. Parrish WR, et al. (2008) Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14:567–74.
19. de Jonge WJ, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6:844–51.
20. van Westerloo DJ, et al. (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 130:1822–30.
21. Krzyzaniak MJ, et al. (2011) Efferent vagal nerve stimulation attenuates acute lung injury following burn: The importance of the gut-lung axis. Surgery. 150:379–89.
22. Huston JM, et al. (2009) Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J. Immunol. 183:552–9.
23. Van Maanen M, Vervoordeldonk M, Tak P. (2009) The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 5:229–32.
24. Koopman FA, et al. (2011) Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 17:937–48.
25. Bevaart L, Vervoordeldonk MJ, Tak PP. (2010) Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum. 62:2192–205.
26. Hegen M, Keith JC Jr, Collins M, Nickerson-Nutter CL. (2008) Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann. Rheum. Dis. 67:1505–15.
27. Li T, et al. (2010) The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. J. Clin. Immunol. 30:213–20.
28. Wu S, et al. (2014) Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur. J. Pharmacol. 735:97–104.
29. van Maanen M, Stoof S, Larosa G, Vervoordeldonk M, Tak P. (2010) Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann. Rheum. Dis. 69:1717–23.
30. van Maanen MA. (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60:114–122.
31. Zhang P, Han D, Tang T, Zhang X, Dai K. (2008) Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm. Res. 57:322–328.
32. Levine YA, et al. (2014) Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One. 9:e104530.
33. Lacey DL, et al. (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat. Rev. Drug. Discov. 11:401–19.
34. Zhou Y, et al. (2012) Nicotine inhibits tumor necrosis factor-alpha induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol. Int. 32:97–104.
35. van Maanen MA, et al. (2009) The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 60:1272–81.
36. Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. (2008) Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 58:3439–49.
37. Andersson ML, Bergman S, Soderlin MK, BARFOT study group (2013) The effect of snuff (smokeless tobacco) on disease activity and function in rheumatoid arthritis: experiences from the Better Anti-Rheumatic Farmac O Therapy, a longitudinal multicenter study on early rheumatoid arthritis. J. Clin. Rheumatol. 19:14–18.
38. Valatas V, Vakas M, Kolios G. (2013) The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am. J. Physiol. Gastrointest. Liver Physiol. 305:G763–85.
39. Ostanin DV, et al. (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G135–46.
40. Perse M, Cerar A. (2012) Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012:718617.
41. te Velde AA, Verstege MI, Hommes DW. (2006) Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 12:995–9.
42. Rennick DM, Fort MM. (2000) Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(−/−) mice and intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G829–33.
43. Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Fich A. (1998) Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur. J. Gastroenterol. Hepatol. 10:1013–9.
44. Snoek SA, et al. (2010) Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br. J. Pharmacol. 160:322–33.
45. Meregnani J, et al. (2011) Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton. Neurosci. 160:82–9.
46. Sun P, et al. (2013) Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One. 8:e69424.
47. Famm K, Litt B, Tracey KJ, Boyden ES, Slaoui M. (2013) Drug discovery: a jump-start for electroceuticals. Nature. 496:159–61.
48. van Maanen M, et al. (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60:114–22.
49. Sykes AP, et al. (2000) An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm. Res. 49:311–9.
50. Eliakim R, Fan QX, Babyatsky MW. (2002) Chronic nicotine administration differentially alters jejunal and colonic inflammation in interleukin-10 deficient mice. Eur. J. Gastroenterol. Hepatol. 14:607–14.
51. Miceli PC, Jacobson K. (2003) Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Auton. Neurosci. 105:16–24.
52. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. (2006) The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology. 131:1122–30.
53. Bai A, Guo Y, Lu N. (2007) The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand. J. Immunol. 66:538–45.
54. Ghia JE, et al. (2009) Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology. 136:2280–8.
55. O’Mahony C, van der Kleij H, Bienenstock J, Shanahan F, O’Mahony L. (2009) Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297:R1118–26.
56. Galitovskiy V, et al. (2011) Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J. Immunol. 187:2677–87.